2019（第四届）外泌体与疾病研讨会
在成功举办前三届外泌体会议的基础上，本次大会围绕外泌体的生物学功能发现、在肿瘤中的作用机制、临床开发应用，以及分离提纯检测等内容，邀请科研院所知名专家学者、行业领军企业管理层、医院相关科室临床医生等进行探讨，分享最新进展，交流心得经验，共同推动外泌体基础应用研究更进一步，促进技术的临床转化和应用。
2019 (5th) International Conference on Gut Microecology and Health
At present, gut microbiome is a hot topic, which draws much attention. Due to its curative effects on multiple diseases, gut microbiome is closely related to human health. Under the development of microbe imaging, metabolomics and single-cell sequencing technologies, new progress has been made in this field.
2019（第七届）先进体外诊断行业峰会
此次峰会将围绕国内IVD产业存在的实际问题和实际需求，设置多个论坛和专场模块，力求为产业发展提供创新思路和解决方案。大会将邀请来自政府机构、学会的专家，国内外IVD龙头企业的高层管理者以及国内三甲医院的临床检验人员，IVD行业知名专家，共同讨论IVD各领域法规、产品、市场、模式、技术等多方面的话题。
2019上海交通大学精准医疗产业精英研修班第二期
精准医疗产业精英研修班第二期课程将于2019年3月正式开课，通过权威师资、系统学习、实战演练、长期交流四位一体的方式，旨在帮助医疗健康领域创业者提高创业成功率，加快企业健康成长，助推医疗产业的高速发展。
2018 (4th) International Symposium on Next-Generation CAR & TCR-T Cells
Chimeric antigen receptors are engineered receptors that combine a new specificity with an immune cell to target cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
2018 China Summit of Probiota
Probiota is a group of microorganisms that are claimed to provide health benefits when consumed. The introduction of the concept (but not the term) is generally attributed to Nobel laureate Élie Metchnikoff, who postulated that yogurt-consuming Bulgarian peasants lived longer lives because of this custom.
2018 ( 10th ) International Conference on Stem Cells
After nearly 20 years' development, there have been almost 100 companies focusing on technology R&D on stem cells, establishment of stem cell banks and application of stem cells. This conference will facilitate communication and cooperation among researchers at home and abroad.
2018 International Forum on Innovative Drug R&D
With a population of 1.3 billion people and a rapidly expanding economy, China has recently risen to become the third largest pharmaceutical market globally. Several multinational pharmaceutical companies have now located R&D centres in China, and Chinese pharmaceutical companies are increasingly focusing on innovative drug R&D.
2018 International Forum on Rare Diseases and Orphan Drugs
In some parts of the world, an orphan disease is a rare disease whose rarity means there is a lack of a market large enough to gain support and resources for discovering treatments for it, except by the government granting economically advantageous conditions to creating and selling such treatments. Orphan drugs are ones so created or sold.
2018 International Symposium on Neonatal Hereditary Diseases and Translational Medicine
Monogenic diseases are frequent causes of neonatal morbidity and mortality, and disease presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneity.